Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 1, Iss. 1, 2005-01 ,pp. : 65-73

Bentham Science Publishers

Access to resources Recommend Favorite

Three-dimensional quantitative structure–farnesyltransferase inhibition analysis for some diaminobenzophenones

By Xie Aihua   Clark Shawna R.   Prasanna Sivaprakasam   Doerksen Robert J.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 6, 2009-12 ,pp. : 1220-1228

Informa Healthcare

Access to resources Recommend Favorite

Requirement of c-Jun N-Terminal Kinase for Apoptotic Cell Death Induced by Farnesyltransferase Inhibitor, Farnesylamine, in Human Pancreatic Cancer Cells

By Mizukami Y.   Ura H.   Obara T.   Habiro A.   Izawa T.   Osanai M.   Yanagawa N.   Tanno S.   Kohgo Y.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 1, 2001-10 ,pp. : 198-204

Elsevier

Access to resources Recommend Favorite

Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes

By  

Current Enzyme Inhibition, Vol. 7, Iss. 4, 2011-12 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of P450 Enzymes: An In Vitro Approach

By  

Current Enzyme Inhibition, Vol. 2, Iss. 3, 2006-08 ,pp. : 281-304

Bentham Science Publishers

Access to resources Recommend Favorite